• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大多数肾性高钙尿症患者不存在继发性甲状旁腺功能亢进。

Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.

作者信息

Olmer M, Berland Y, Argemi B

出版信息

Kidney Int Suppl. 1983 Dec;16:S175-9.

PMID:6330424
Abstract

We examined parathyroid gland function in 47 patients with idiopathic hypercalciuria in an effort to determine whether serum levels of parathyroid hormone (PTH) and/or urinary excretion of cyclic adenosine monophosphate (cyclic AMP) can discriminate between the various forms of hypercalciuria. Although we could separate our 47 patients into two groups, 21 patients with renal hypercalciuria (RH) and 15 patients with absorptive hypercalciuria (AH), there remained a group of 11 patients who did not exactly correspond to either group. Basal serum PTH was normal in the two groups: for RH, 10.32 +/- 0.93; for AH, 11.43 +/- 1.10 microliter Eq/ml. Similarly, urinary cyclic AMP did not differ between the two groups: for RH, 4.88 +/- 0.5; for AH, 4.87 +/- 0.55 nmoles/dl/min GFR. Moreover, the response of the parathyroid glands to acute hypocalcemia produced by intravenous infusion of EDTA was not different among patients with AH, RH, and control subjects. Only one patient showed a marked increase of serum PTH in response to acute hypocalcemia, and the bone biopsy revealed increased osteoclastic resorption. In conclusion, our data show that serum levels of PTH and urinary cyclic AMP do not differentiate between the various forms of idiopathic hypercalciuria. The EDTA test demonstrated that secondary hyperparathyroidism is very uncommon in these patients.

摘要

我们对47例特发性高钙尿症患者的甲状旁腺功能进行了检查,以确定血清甲状旁腺激素(PTH)水平和/或尿中环磷酸腺苷(环磷腺苷)排泄量是否能够区分不同类型的高钙尿症。尽管我们可以将47例患者分为两组,即21例肾性高钙尿症(RH)患者和15例吸收性高钙尿症(AH)患者,但仍有11例患者不完全符合这两组中的任何一组。两组患者的基础血清PTH均正常:RH组为10.32±0.93;AH组为11.43±1.10微升当量/毫升。同样,两组患者的尿环磷腺苷也无差异:RH组为4.88±0.5;AH组为4.87±0.55纳摩尔/分升/分钟肾小球滤过率。此外,AH患者、RH患者和对照受试者对静脉输注EDTA引起的急性低钙血症的甲状旁腺反应无差异。只有1例患者对急性低钙血症反应时血清PTH显著升高,骨活检显示破骨细胞吸收增加。总之,我们的数据表明,PTH血清水平和尿环磷腺苷不能区分不同类型的特发性高钙尿症。EDTA试验表明,这些患者中继发性甲状旁腺功能亢进非常少见。

相似文献

1
Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.大多数肾性高钙尿症患者不存在继发性甲状旁腺功能亢进。
Kidney Int Suppl. 1983 Dec;16:S175-9.
2
The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.1α,25 - 二羟维生素D在原发性甲状旁腺功能亢进症和吸收性高钙尿症中肠道钙吸收亢进介导过程中的作用
J Clin Invest. 1977 May;59(5):756-60. doi: 10.1172/JCI108696.
3
The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.特发性高钙尿症的发病机制:甲状旁腺功能亢进的证据。
Q J Med. 1984 Winter;53(209):41-53.
4
Pathophysiology and therapy of hypercalciuria in patients who form recurrent stones.复发性结石形成患者高钙尿症的病理生理学与治疗
Eur Urol. 1975;1(3):131-3.
5
The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.高钙尿症。病因、甲状旁腺功能及诊断标准。
J Clin Invest. 1974 Aug;54(2):387-400. doi: 10.1172/JCI107774.
6
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
7
Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.特发性高钙尿症的病理生理学研究:采用口服钙耐量试验对不同的高钙尿症亚组进行特征描述。
J Clin Endocrinol Metab. 1978 Oct;47(4):751-60. doi: 10.1210/jcem-47-4-751.
8
Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.甲状旁腺激素对人体血浆和尿中3',5'-单磷酸腺苷的影响。
J Clin Invest. 1970 Dec;49(12):2387-95. doi: 10.1172/JCI106458.
9
Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism.家族性良性高钙血症和原发性甲状旁腺功能亢进症中尿中环磷酸腺苷对外源性和内源性甲状旁腺激素的反应。
J Lab Clin Med. 1980 Dec;96(6):974-84.
10
[Hypercalciuria, primary hyperparathyroidism and calcium nephrolithiasis].
Vutr Boles. 1984;23(2):1-7.

引用本文的文献

1
Effect of thiazides on bone mineral density in children with idiopathic hypercalciuria.噻嗪类药物对特发性高钙尿症儿童骨密度的影响。
Pediatr Nephrol. 2012 Feb;27(2):261-8. doi: 10.1007/s00467-011-1987-6. Epub 2011 Aug 28.
2
RANKL is a mediator of bone resorption in idiopathic hypercalciuria.核因子κB受体活化因子配体(RANKL)是特发性高钙尿症中骨吸收的介质。
Clin J Am Soc Nephrol. 2008 Sep;3(5):1446-52. doi: 10.2215/CJN.00240108. Epub 2008 May 14.
3
Classification of idiopathic hypercalciuric patients by isotopic calcium absorption: a comparison with oral calcium tolerance test.
Calcif Tissue Int. 1985 Sep;37(5):467-73. doi: 10.1007/BF02557828.